Home2196 • HKG
add
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
Previous close
$14.80
Day range
$14.70 - $15.10
Year range
$11.52 - $19.50
Market cap
62.83B HKD
Avg Volume
5.35M
P/E ratio
20.32
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Revenue | 10.16B | -5.09% |
Operating expense | 4.25B | -14.46% |
Net income | 759.24M | 635.70% |
Net profit margin | 7.48 | 679.17% |
Earnings per share | — | — |
EBITDA | 1.00B | 115.25% |
Effective tax rate | 9.46% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 16.12B | 3.45% |
Total assets | 117.46B | 3.52% |
Total liabilities | 57.53B | 1.18% |
Total equity | 59.93B | — |
Shares outstanding | 2.66B | — |
Price to book | 0.83 | — |
Return on assets | 0.79% | — |
Return on capital | 0.96% | — |
Cash Flow
Net change in cash
(CNY) | Dec 2024info | Y/Y change |
---|---|---|
Net income | 759.24M | 635.70% |
Cash from operations | 1.49B | 56.45% |
Cash from investing | -1.17B | -119.37% |
Cash from financing | -500.30M | 46.76% |
Net change in cash | -85.94M | 85.18% |
Free cash flow | 2.92B | 9.19% |
About
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International.
As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
Founded
1994
Website
Employees
40,557